Chronic Hemodialysis clinical trials

Explore recruiting chronic hemodialysis clinical trials.

Recruiting chronic hemodialysis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Hemodialysis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Chronic anticoagulation in end-stage renal disease patients: pharmacocinetics and pharmacodynamic of a reduced dose regimen of rivaroxaban (CARD-AXA)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

CLEARTOX: Development of an innovative haemodialysis method to improve dialytic clearance of protein-bound uraemic toxins

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Long-term muscle synthetic effects of intradialytic parenteral nutrition in chronic hemodialysis patients

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Pharmacokinetics study of Cefazolin in haemodialysis (CEFAZODIAL)

France

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Dose-Titrated PLS240 in the Treatment of Secondary Hyperparathyroidism in Individuals with End Stage Kidney Disease on Hemodialysis (PATH-2) With an Open-Label Extension

Portugal, Bulgaria, Spain, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF DOSE-TITRATED PLS240 IN THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN INDIVIDUALS WITH END STAGE KIDNEY DISEASE ON HEMODIALYSIS (PATH-1) WITH AN OPEN-LABEL EXTENSION

Poland, Portugal, Spain, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic Hemodialysis trials by city

Chronic Hemodialysis clinical trials

Recruiting chronic hemodialysis studies right now

Functionality of Albumin in the Context of Hemodialysis

A Comparative Study of Intradialytic vs. Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialysis: A Randomized Controlled Trial

AI-Guided Relaxation for Hemodialysis Anxiety

Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients

Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

Exercise During Hemodialysis: Impact on Sarcopenia and Sleep Quality

Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study

Incremental Hemodialysis: The TwoPlus Trial

Lumasiran in Hyperoxalaemic Patients on Haemodialysis

Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients

A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

Transforming Hemodialysis-Related Vascular Access Education

Also recruiting in Europe

Chronic anticoagulation in end-stage renal disease patients: pharmacocinetics and pharmacodynamic of a reduced dose regimen of rivaroxaban (CARD-AXA)

CLEARTOX: Development of an innovative haemodialysis method to improve dialytic clearance of protein-bound uraemic toxins

Long-term muscle synthetic effects of intradialytic parenteral nutrition in chronic hemodialysis patients

Pharmacokinetics study of Cefazolin in haemodialysis (CEFAZODIAL)

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Dose-Titrated PLS240 in the Treatment of Secondary Hyperparathyroidism in Individuals with End Stage Kidney Disease on Hemodialysis (PATH-2) With an Open-Label Extension

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF DOSE-TITRATED PLS240 IN THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN INDIVIDUALS WITH END STAGE KIDNEY DISEASE ON HEMODIALYSIS (PATH-1) WITH AN OPEN-LABEL EXTENSION

Chronic Hemodialysis trials by city

Other conditions